Class information for:
Level 1: REDUCED HALOPERIDOL//BROMPERIDOL//REDUCED BROMPERIDOL

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
4999 1620 30.0 48%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)



ID, lev.
above
Publications Label for level above
278 18430 RISPERIDONE//CLOZAPINE//OLANZAPINE

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 REDUCED HALOPERIDOL Author keyword 53 78% 2% 35
2 BROMPERIDOL Author keyword 35 76% 2% 25
3 REDUCED BROMPERIDOL Author keyword 14 100% 0% 7
4 SCHIZOPHRENIA DRUG THERAPY Author keyword 8 44% 1% 14
5 HPTP Author keyword 6 80% 0% 4
6 FLUPHENAZINE DECANOATE Author keyword 6 50% 0% 8
7 HALOPERIDOL DECANOATE Author keyword 5 38% 1% 10
8 BASIC METABOLITE Author keyword 4 75% 0% 3
9 ANTIPSYCHOTIC AGENTS THERAPEUTIC USE Author keyword 4 35% 1% 9
10 BENPERIDOL Author keyword 3 57% 0% 4

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
LCSH search Wikipedia search
1 REDUCED HALOPERIDOL 53 78% 2% 35 Search REDUCED+HALOPERIDOL Search REDUCED+HALOPERIDOL
2 BROMPERIDOL 35 76% 2% 25 Search BROMPERIDOL Search BROMPERIDOL
3 REDUCED BROMPERIDOL 14 100% 0% 7 Search REDUCED+BROMPERIDOL Search REDUCED+BROMPERIDOL
4 SCHIZOPHRENIA DRUG THERAPY 8 44% 1% 14 Search SCHIZOPHRENIA+DRUG+THERAPY Search SCHIZOPHRENIA+DRUG+THERAPY
5 HPTP 6 80% 0% 4 Search HPTP Search HPTP
6 FLUPHENAZINE DECANOATE 6 50% 0% 8 Search FLUPHENAZINE+DECANOATE Search FLUPHENAZINE+DECANOATE
7 HALOPERIDOL DECANOATE 5 38% 1% 10 Search HALOPERIDOL+DECANOATE Search HALOPERIDOL+DECANOATE
8 BASIC METABOLITE 4 75% 0% 3 Search BASIC+METABOLITE Search BASIC+METABOLITE
9 ANTIPSYCHOTIC AGENTS THERAPEUTIC USE 4 35% 1% 9 Search ANTIPSYCHOTIC+AGENTS+THERAPEUTIC+USE Search ANTIPSYCHOTIC+AGENTS+THERAPEUTIC+USE
10 BENPERIDOL 3 57% 0% 4 Search BENPERIDOL Search BENPERIDOL

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 REDUCED HALOPERIDOL 44 46% 5% 73
2 BUTYROPHENONES 38 93% 1% 14
3 PLASMA HALOPERIDOL 36 83% 1% 20
4 VISCOLEO 26 100% 1% 11
5 FLUPHENAZINE DECANOATE 22 34% 3% 53
6 PLASMA HALOPERIDOL LEVELS 19 61% 1% 20
7 DEBRISOQUINE HYDROXYLATION PHENOTYPE 18 48% 2% 27
8 NEUROTOXIC PYRIDINIUM METABOLITE 17 48% 2% 26
9 FLUPHENAZINE 17 28% 3% 50
10 INTERMITTENT NEUROLEPTIC PROPHYLAXIS 16 54% 1% 20

Journals

Reviews



Title Publ. year Cit. Active references % act. ref.
to same field
SIGNIFICANCE OF NEUROLEPTIC DOSE AND PLASMA-LEVEL IN THE PHARMACOLOGICAL TREATMENT OF PSYCHOSES 1988 408 62 77%
The relationship between serum concentration and therapeutic effect of haloperidol in patients 1998 46 87 78%
Psychopharmacology and adverse effects of antipsychotic long-acting injections: a review 2009 29 55 51%
Intramuscular preparations of antipsychotics - Uses and relevance in clinical practice 2003 59 80 41%
NEUROLEPTIC WITHDRAWAL IN SCHIZOPHRENIC-PATIENTS - A REVIEW OF THE LITERATURE 1995 247 54 28%
Role of Haloperidol in Palliative Medicine: An Update 2012 10 33 36%
Lack of impact of CYP1A2 genetic polymorphism (C/A polymorphism at position 734 in intron 1 and G/A polymorphism at position -2964 in the 5 '-flanking region of CYP1A2) on the plasma concentration of haloperidol in smoking male Japanese with schizophrenia 2002 24 20 75%
PLASMA-LEVEL MONITORING OF ANTIPSYCHOTIC-DRUGS CLINICAL UTILITY 1986 106 100 91%
Sensitive detection of haloperidol and hydroxyzine at multi-walled carbon nanotubes-modified glassy carbon electrodes 2008 9 15 40%
Pharmacokinetics of haloperidol - An update 1999 91 182 34%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ.
in class
1 HARVEY W PETERS STUDY PARKINSONS DIS DISORD 2 50% 0.2% 3
2 OCTSPAN 1 100% 0.1% 2
3 PSYCHIAT NEUROPSYCHIAT UNIT 1 50% 0.1% 2
4 COCHRANE IZOPHRENIA GRP 1 13% 0.6% 9
5 CONTINUING PSYCHIAT SERV IZOPHRENIA RELATED 1 50% 0.1% 1
6 ESTEEM 1 50% 0.1% 1
7 FERNAND SEQUIN 1 50% 0.1% 1
8 KLIN POLIKLIN PSYCIAT PSYCHOTHER IE 1 50% 0.1% 1
9 KYUSHU S 1 50% 0.1% 1
10 BIPOLAR PSYCHIAT DISORDERS PROGRAM 0 33% 0.1% 1

Related classes at same level (level 1)



Rank Relatedness score Related classes
1 0.0000191323 COCHRANE IZOPHRENIA GRP//WARM SUPPLEMENTING KIDNEY YANG//SURG DEV SCI
2 0.0000123180 PALIPERIDONE PALMITATE//LONG ACTING RISPERIDONE//OLANZAPINE PAMOATE
3 0.0000115478 PHVA//PLASMA HOMOVANILLIC ACID//HOMOVANILLIC ACID
4 0.0000105545 PHENOTHIAZINE DRUGS//CHLORPROMAZINE HCL//PROMETHAZINE HYDROCHLORIDE
5 0.0000092418 ACUTE AGITATION//INHALED LOXAPINE//INTRAMUSCULAR HALOPERIDOL
6 0.0000083559 PAINFUL LEGS AND MOVING TOES//MOVING TOES//PAINFUL LEGS
7 0.0000083122 CLOZAPINE//RISPERIDONE//OLANZAPINE
8 0.0000081062 ANTIPSYCHOTIC POLYPHARMACY//POLYPHARMACY//TUNKU ABDUL RAHMAN NEUROSCI
9 0.0000078596 9 HYDROXYRISPERIDONE//NORCLOZAPINE//PALIPERIDONE
10 0.0000072720 CLINICAL GLOBAL IMPRESSIONS SCALE//FUNCTIONAL REMISSION//SYMPTOMATIC REMISSION